Advisorshares Pure Cannabis Etf ETF News

US President Joe Biden confirmed on Thursday that the Justice Department is officially moving toward reclassifying cannabis as a lower-risk drug. The Justice Department's proposed rule will soon be po

On this week's episode of ETF Prime, host Nate Geraci is joined by VettaFi Head of Research Todd Rosenbluth to discuss hedge funds embracing ETFs, spot ether ETFs, and a potential shortage of ETF tick

Looking at the ETFs with the highest returns YTD, a few thematic standouts have emerged.  As a reminder regarding  long-term investments, thematic investing is cyclical.

Marijuana ETFs and cannabis stocks shot higher last week after the U.S. Justice Department said it plans to reclassify marijuana as a less dangerous drug.

The proposed rescheduling of cannabis is the biggest step forward for the industry in decades.

Shares of cannabis companies surged on Tuesday afternoon after the U.S. Department of Justice (DoJ) moved to reclassify marijuana as a less dangerous drug.

The Canadian cannabis industry is in a shakeout phase, with poorly run businesses struggling and the industry maturing.

With April 20 approaching (a notable cannabis celebration indeed), thoughts may turn to investing in marijuana stocks. However, beyond the symbolic date, imminent catalysts could drive significant gro

As the first quarter comes to a close, clearly, there have been some thematic winners in terms of flows and investment performance. Artificial Intelligence AI-themed ETFs remain among the top recipien

In a White House meeting, Vice President Kamala Harris this week urged the DEA to expedite the rescheduling of marijuana, criticizing its current Schedule 1 classification as "absurd" and "patently un

Cannabis stocks on Friday booked their fifth-straight week of positive returns led by the Advisorshares Pure US Cannabis ETF (MSOS) which gained 12% to finish the week at about $10.30. The Advisorshar

The cannabis industry has been performing well this year after the US Drug Enforcement Administration started reviewing the potential reclassification of cannabis from Schedule I to Schedule III.

Marijuana stocks spiked following the report that the US Drug Enforcement Administration (DEA) is reviewing the potential reclassification of cannabis from Schedule I to Schedule III.

Investing In Cannabis? Stay Patient, Be Ready

This article attempts to assess and rank the relative growth potential of the separate competitors in the cannabis industry. Long-term trends show projected growth in the U.S., Canadian, and global ca